Clinical Trials Logo

Partial Onset Seizures clinical trials

View clinical trials related to Partial Onset Seizures.

Filter by:

NCT ID: NCT01830868 Completed - Clinical trials for Partial Onset Seizures

A Post-marketing Observational Study Of The Use Of Zonisamide (ZNS) in the Adjunctive Treatment Of Adult Patients With Partial Onset Seizures (Study E2090-E044-410) (ZOOM)

Start date: March 2012
Phase:
Study type: Observational

This is a Non-interventional Prospective Study. Centres will enroll adult patients with partial onset seizures for whom the clinician has decided to initiate ZNS as an adjunctive therapy prior to the decision to take part in this study. Patients to be enrolled into the study are not sufficiently controlled with one dug licensed for the use of monotherapy in partial onset seizures. Patients will be seen at baseline and then during normal clinical visits at intervals which are appropriate to the typical practice of the treating clinician. Patients will be assessed at baseline and then at least 3 and 6 months after the baseline.

NCT ID: NCT01830400 Completed - Clinical trials for Partial Onset Seizures

A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS)

Start date: April 2012
Phase: N/A
Study type: Observational

This was a Non-interventional Prospective Study. Centres enrolled adult patients with partial-onset seizures with or without secondary generalisation for whom the clinician had decided to initiate Eslicarbazepine Acetate (ESL) as an adjunctive therapy prior to the decision to take part in this study. Patients enrolled into the study were not sufficiently controlled with one drug licensed for the use as monotherapy in partial-onset seizures. Patients were seen at baseline and then during normal clinical visits at intervals. Patients in this study were assessed for efficacy and tolerability at baseline and then at least 3 and 6 months after the baseline.

NCT ID: NCT01710657 Completed - Epilepsy Clinical Trials

A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures

Start date: September 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of 200 and 400 mg/day of orally administered Lacosamide as adjunctive therapy compared with placebo in Japanese and Chinese adults with uncontrolled Partial-Onset Seizures with or without secondary generalization.

NCT ID: NCT01618695 Completed - Clinical trials for Partial-onset Seizures

A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures

Start date: May 15, 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to confirm the efficacy and safety of perampanel compared to placebo in patients with refractory partial-onset seizures

NCT ID: NCT01506882 Completed - Epilepsy Clinical Trials

An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy

Start date: December 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of Levetiracetam (LEV) used as monotherapy, with efficacy measured as 6-month seizure freedom at the last evaluated dose in the LEV 1000 mg/day to 2000 mg/day group, in newly or recently diagnosed epilepsy subjects.

NCT ID: NCT01407523 Completed - Epilepsy Clinical Trials

An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures

Start date: July 2011
Phase: Phase 2
Study type: Interventional

To evaluate the safety of Levetiracetam IV 15-minute infusion administered every 12 hours as adjunctive treatment in subjects with Partial Onset Seizures after switching from the equivalent Levetiracetam oral dose.

NCT ID: NCT01338805 Completed - Clinical trials for Partial Onset Seizures

Phase II BGG492 Capsule Extension for Partial Epilepsy

Start date: June 2011
Phase: Phase 2
Study type: Interventional

This long-term extension study will assess the safety, tolerability and efficacy of BGG492 as adjunctive treatment in patients with partial onset seizures.

NCT ID: NCT01147003 Completed - Clinical trials for Partial Onset Seizures

Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures

Start date: June 2010
Phase: Phase 2
Study type: Interventional

This study will assess the efficacy and safety of BGG492 as adjunctive treatment in patients with partial onset seizures.

NCT ID: NCT01051193 Completed - Clinical trials for Partial Onset Seizures

Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures

Start date: January 5, 2010
Phase: Phase 2/Phase 3
Study type: Interventional

This study is designed to provide long term safety data of TRI476 in children with inadequately-controlled partial seizures. This study is conducted in patients who complete the core study CTRI476B1301. Blinding is maintained during the transition and dose adjustment phase of the extension study. All patients are treated with TRI476 from the dose adjustment phase onwards. The purpose of study is to confirm that TRI476 as adjunctive therapy is safe.

NCT ID: NCT00975715 Completed - Clinical trials for Partial Onset Seizures

Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures

Start date: September 2009
Phase: Phase 2/Phase 3
Study type: Interventional

This study is designed to provide short term efficacy and safety data of TRI476 in children with inadequately-controlled partial seizures. Patients will be randomized into either drug treatment or placebo group at 1:1 ratio, and receive their respective treatment for 8 weeks. The purpose of study is to confirm that TRI476 as adjunctive therapy is effective and safe.